Abstract
Background: Nowadays the residual tumor after neoadjuvant treatment (NACT) is evaluated by magnetic resonance (MR). Our study has the main objective of estimating MR imaging (MRI) accuracy in finding a complete response to neoadjuvant chemotherapy and estimating the correlation between the size of the residual tumour mass appreciated with MRI after NACT and the size of the residual disease evaluated by post-operative histological examination.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
